耶尔森菌感染

CDC Division of Vector-Borne Infectious Diseases. Plague. September 2015. http://www.cdc.gov/ (last accessed 3 July 2017).

• 全文

Prentice MB, Rahalison L. Plague. Lancet. 2007;369:1196-1207.

• 摘要

Inglesby TV, Dennis DT, Henderson DA, et al. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA. 2000;283:2281-2290.

• 全文
• 摘要

World Health Organization. Plague manual: epidemiology, distribution, surveillance and control. Geneva, Switzerland: World Health Organization; 1999.

• 全文

1.  Naktin J, Beavis KG. Yersinia enterocolitica and Yersinia pseudotuberculosis. Clin Lab Med. 1999;19:523-536.

• 摘要

2.  Cover TL, Aber RC. Yersinia enterocolitica. N Engl J Med. 1989;321:16-24.

• 摘要

3.  Taccetti G, Trapani S, Ermini M, et al. Reactive arthritis triggered by Yersinia enterocolitica: a review of 18 pediatric cases. Clin Exp Rheumatol. 1994;12:681-684.

• 摘要

4.  Kool JL. Risk of person-to-person transmission of pneumonic plague. Clin Infect Dis. 2005;40:1166-1172.

• 全文
• 摘要

5.  World Health Organization. Human plague in 2002 and 2003. Wkly Epidemiol Rec. 2004;79:301-308.

• 全文
• 摘要

6.  Koirala J. Plague: disease, management, and recognition of act of terrorism. Infect Dis Clin North Am. 2006;20:273-287.

• 摘要

7.  Craven RB, Maupin GO, Beard ML, et al. Reported cases of human plague infections in the United States, 1970-1991. J Med Entomol. 1993;30:758-761.

• 摘要

8.  Gage KL, Dennis DT, Orloski KA, et al. Cases of cat-associated human plague in the Western US, 1977-1998. Clin Infect Dis. 2000;30:893-900.

• 全文
• 摘要

9.  CDC Division of Vector-Borne Infectious Diseases. Plague. September 2015. http://www.cdc.gov/ (last accessed 3 July 2017).

• 全文

10.  CDC. Red blood cell transfusions contaminated with Yersinia enterocolitica: United States, 1991-1996, and initiation of a national study to detect bacteria-associated transfusion reactions. MMWR Morb Wkly Rep. 1997;46:553-555.

• 摘要

11.  Centers for Disease Control and Prevention. FoodNet data and reports. April 2016. http://www.cdc.gov/foodnet/reports/index.html (last accessed 3 July 2017).

• 全文

12.  Merilahti-Palo R, Lahesmaa R, Granfors K, et al. Risk of Yersinia infection among butchers. Scand J Infect Dis. 1991;23:55-61.

• 摘要

13.  Prentice MB, Rahalison L. Plague. Lancet. 2007;369:1196-1207.

• 摘要

14.  Begier EM, Asiki G, Anywaine Z, et al. Pneumonic plague cluster, Uganda, 2004. Emerg Infect Dis. 2006;12:460-467.

• 全文
• 摘要

15.  Metchock B, Lonsway DR, Carter GP, et al. Yersinia enterocolitica: a frequent seasonal stool isolate from children at an urban hospital in the southeast United States. J Clin Microbiol. 1991;29:2868-2869.

• 全文
• 摘要

16.  Ostroff SM, Kapperud G, Hutwagner LC, et al. Sources of sporadic Yersinia enterocolitica infections in Norway: a prospective case-control study. Epidemiol Infect. 1994;112:133-141.

• 摘要

17.  Smiley ST. Current challenges in the development of vaccines for pneumonic plague. Expert Rev Vaccines. 2008;7:209-221.

• 全文
• 摘要

18.  Inglesby TV, Dennis DT, Henderson DA, et al. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA. 2000;283:2281-2290.

• 全文
• 摘要

19.  World Health Organization. Plague manual: epidemiology, distribution, surveillance and control. Geneva, Switzerland: World Health Organization; 1999.

• 全文

20.  Boulanger LL, Ettestad P, Fogarty JD, et al. Gentamicin and tetracyclines for the treatment of human plague: review of 75 cases in New Mexico, 1985-1999. Clin Infect Dis. 2004;38:663-669.

• 全文
• 摘要

21.  Garcia E, Elliott JM, Ramanculov E, et al. The genome sequence of Yersinia pestis bacteriophage phiA1122 reveals an intimate history with the coliphage T3 and T7 genomes. J Bacteriol. 2003;185:5248-5262.

• 全文
• 摘要

22.  Kachoris M, Ruoff KL, Welch K, et al. Routine culture of stool specimens for Yersinia enterocolitica is not a cost-effective procedure. J Clin Microbiol. 1988;26:582-583.

• 全文
• 摘要

23.  Alsofrom DJ, Mettler FA Jr, Mann JM. Radiographic manifestations of plague in New Mexico, 1975-1980: a review of 42 proved cases. Radiology. 1981;139:561-565.

• 摘要

24.  Maki-Ikola O, Heesemann J, Toivanen A, et al. High frequency of Yersinia antibodies in healthy populations in Finland and Germany. Rheumatol Int. 1997;16:227-229.

• 摘要

25.  Chanteau S, Rahalison L, Ralafiarisoa L, et al. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet. 2003;361:211-216.

• 摘要

26.  Rahalison L, Vololonirina E, Ratsitorahina M, et al. Diagnosis of bubonic plague by PCR in Madagascar under field conditions. J Clin Microbiol. 2000;38:260-263.

• 全文
• 摘要

27.  Boisier P, Rahalison L, Rasolomaharo M, et al. Epidemiologic features of four successive annual outbreaks of bubonic plague in Mahajanga, Madagascar. Emerg Infect Dis. 2002;8:311-316.

• 全文
• 摘要

28.  Ratsitorahina M, Chanteau S, Rahalison L, et al. Epidemiological and diagnostic aspects of the outbreak of pneumonic plague in Madagascar. Lancet. 2000;355:111-113.

• 摘要

29.  Mwengee W, Butler T, Mgema S, et al. Treatment of plague with gentamicin or doxycycline in a randomized clinical trial in Tanzania. Clin Infect Dis. 2006;42:614-621.

• 全文
• 摘要

30.  Steward J, Lever MS, Russell P, et al. Efficacy of the latest fluoroquinolones against experimental Yersinia pestis. Int J Antimicrob Agents. 2004;24:609-612.

• 摘要

31.  Welty TK, Grabman J, Kompare E, et al. Nineteen cases of plague in Arizona: a spectrum including ecthyma gangrenosum due to plague and plague in pregnancy. West J Med. 1985;142:641-646.

• 全文
• 摘要

32.  Adalja AA, Toner E, Inglesby TV. Clinical management of potential bioterrorism-related conditions. N Engl J Med. 2015;372:954-962.

• 全文
• 摘要

33.  Hoogkamp-Korstanje JA. Antibiotics in Yersinia enterocolitica infections. J Antimicrob Chemother. 1987;20:123-131.

• 摘要

34.  Gayraud M, Scavizzi MR, Mollaret HH, et al. Antibiotic treatment of Yersinia enterocolitica septicemia: a retrospective review of 43 cases. Clin Infect Dis. 1993;17:405-410.

• 摘要

35.  Saebo A, Lassen J. Survival and causes of death among patients with Yersinia enterocolitica infection: a Norwegian 10-year follow-up study on 458 hospitalized patients. Scand J Infect Dis. 1992;24:613-617.

• 摘要

36.  Leirisalo-Repo M, Suoranta H. Ten-year follow-up study of patients with Yersinia arthritis. Arthritis Rheum. 1988;31:533-537.

• 摘要

37.  Mingeot-Leclercq MP, Tulkens PM. Aminoglycosides: nephrotoxicity. Antimicrob Agents Chemother. 1999;43:1003-1012.

• 全文
• 摘要